Curaleaf Holdings Inc
CURA: XTSE (CAN)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
CAD 38.10 | Gxhq | Gcyjvyg |
Curaleaf Profitability Will Continue to Increase Even as Legal Sales Growth Frustratingly Slow
Business Strategy and Outlook
Curaleaf cultivates and sells cannabis in the U.S. with a presence in 19 states. Vertically integrated, Curaleaf produces through its own cultivation sites and sells directly through 152 dispensaries and wholesale to other dispensaries. Compared with other multistate operators, Curaleaf generally employs a more aggressive growth strategy.